Brian Nowosielski

Don Roosan, PharmD, PhD, discussed the artificial intelligence of ChatGPT and how it is currently being used in clinical pharmacy practices.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed her experience when beginning to counsel patients using GLP-1 medications.

Clinical pharmacists were asked to provide interventions to improve their patients’ rate of not showing up to a pharmacy appointment.

The Cut Hypertension Program operates in barbershops across the Bay Area in California. The program’s lead pharmacist joined us to discuss main themes and goals of the new initiative.

Researchers conducted a survey asking pharmacists their perspectives on addressing patients’ social determinants of health.

Researchers investigated the acceptability of community pharmacy-led influenza vaccination and patients’ willingness to return for future immunization.

Researchers analyzed the association between adherence to a Mediterranean diet and obesity cancers, with a focus on the mediating role adiposity plays throughout the process.

In a third installment of our interview series with Chris Robinson, MD, PhD, we looked at the future of pain management and emerging technologies being used for treatment.

Researchers determined the prevalence of weight management interventions among patients who were obese and received an obstructive sleep apnea diagnosis.

Researchers explored the differences in off-label prescribing between pharmacists and physicians among a cohort of patients in pediatric palliative care.

In a search for new treatment and prevention strategies for pain in patients with fibromyalgia, researchers explored bioavailable nutraceuticals and phytochemicals like polyphenols.

GSK announced its ANCHOR-1 and ANCHOR-2 phase 3 trial results for depemokimab’s efficacy and safety in treating patients with chronic rhinosinusitis with nasal polyps.

Researchers explored out-of-pocket spending on maternity care and classified their findings by race and ethnicity.

Exploring data from the past 20 years, researchers investigated the end-organ complications from alcohol in adolescents and young adults.

Chris Robinson, MD, PhD, joined Drug Topics to discuss the importance of education in newly explored technologies for the treatment of pain.

Researchers compared hospitalization and mortality outcomes of older adults with and without restricted access to nirmatrelvir-ritonavir.

As artificial intelligence evolves from a novel technology to commonplace in health care, the pharmacy industry is adapting to its challenges and opportunities.

Researchers conducted a cross-sectional study to investigate the accessibility of over-the-counter naloxone and nonprescription syringes at community pharmacies.

US Secretary of Agriculture Brooke Rollins detailed her organization’s plans to combat the bird flu and quell the concerns of rising grocery store costs.

In a systematic review of antibiotic drug shortages, researchers explored what causes them, how they impact health systems, and what officials commonly do to mitigate them.

Researchers explored the efficacy of a multidisciplinary pain management team for addressing patients with cancer-related pain.

Among postmenopausal women, researchers investigated the association of cardiometabolic parameters and circulating levels of visfatin, adropin, and adiponectin.

Crystal Zhou, PharmD, APh, AHSCP, BCACP, joined Drug Topics to further discuss the Cut Hypertension Program and nontraditional roles within health care.

Researchers investigated the pharmacological management of chronic orofacial pain and provided guidance on its proper treatment.

The next-gen molecular Metrix was given emergency use authorization for its ability to test for SARS-CoV-2 and influenza A and B viruses.

Researchers explore the unification of outpatient practices and the structural racism in large health systems that has caused patient disparities.

Researchers identified factors contributing to Medicaid Managed Care complexities and collected evidence of pharmacists’ ability to address patients’ health needs.

Ctexli is the first FDA-approved treatment for adults with cerebrotendinous xanthomatosis.

Physician with expertise in pain research discussed emerging technologies in the future of pain medicine and how they must be adapted to improve patient outcomes.

Experts gathered to explore the pathophysiology and therapeutic management of burn injury-induced pain.